139 related articles for article (PubMed ID: 38850402)
1. Effectiveness and Safety of Adjunctive Cenobamate in People with Focal-Onset Epilepsy: Evidence from the First Interim Analysis of the BLESS Study.
Lattanzi S; Ranzato F; Di Bonaventura C; Bonanni P; Gambardella A; Tartara E; Assenza G; Procaccini M; Falsetto N; Villano V; Camattari G; Ori A; Di Gennaro G;
Neurol Ther; 2024 Jun; ():. PubMed ID: 38850402
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of adjunctive cenobamate based on number of concomitant antiseizure medications, seizure frequency, and epilepsy duration at baseline: A post-hoc analysis of a randomized clinical study.
Rosenfeld WE; Nisman A; Ferrari L
Epilepsy Res; 2021 May; 172():106592. PubMed ID: 33662894
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial.
Krauss GL; Klein P; Brandt C; Lee SK; Milanov I; Milovanovic M; Steinhoff BJ; Kamin M
Lancet Neurol; 2020 Jan; 19(1):38-48. PubMed ID: 31734103
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive cenobamate in highly active and ultra-refractory focal epilepsy: A "real-world" retrospective study.
Peña-Ceballos J; Moloney PB; Munteanu T; Doyle M; Colleran N; Liggan B; Breen A; Murphy S; El-Naggar H; Widdess-Walsh P; Delanty N
Epilepsia; 2023 May; 64(5):1225-1235. PubMed ID: 36790345
[TBL] [Abstract][Full Text] [Related]
5. Effect of Cenobamate on Cognition in Patients with Drug-Resistant Epilepsy with Focal Onset Seizures: An Exploratory Study.
Serrano-Castro PJ; Ramírez-García T; Cabezudo-Garcia P; Garcia-Martin G; De La Parra J
CNS Drugs; 2024 Feb; 38(2):141-151. PubMed ID: 38265735
[TBL] [Abstract][Full Text] [Related]
6. Treatment simplification to optimize cenobamate effectiveness and tolerability: A real-world retrospective study in Spain.
Rodríguez-Uranga JJ; Sánchez-Caro JM; Hariramani Ramchandani R
Epilepsia Open; 2024 May; ():. PubMed ID: 38800945
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive Cenobamate for Focal-Onset Seizures in Adults: A Systematic Review and Meta-Analysis.
Lattanzi S; Trinka E; Zaccara G; Striano P; Del Giovane C; Silvestrini M; Brigo F
CNS Drugs; 2020 Nov; 34(11):1105-1120. PubMed ID: 32851590
[TBL] [Abstract][Full Text] [Related]
8. Post hoc analysis of a phase 3, multicenter, open-label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications.
Rosenfeld WE; Abou-Khalil B; Aboumatar S; Bhatia P; Biton V; Krauss GL; Sperling MR; Vossler DG; Klein P; Wechsler R
Epilepsia; 2021 Dec; 62(12):3016-3028. PubMed ID: 34633074
[TBL] [Abstract][Full Text] [Related]
9. Safety and Efficacy of Cenobamate for the Treatment of Focal Seizures in Older Patients: Post Hoc Analysis of a Phase III, Multicenter, Open-Label Study.
O'Dwyer R; Stern S; Wade CT; Guggilam A; Rosenfeld WE
Drugs Aging; 2024 Mar; 41(3):251-260. PubMed ID: 38446341
[TBL] [Abstract][Full Text] [Related]
10. Adjunctive cenobamate for the treatment of focal onset seizures in adults with epilepsy: a critical review.
Wheless JW
Expert Rev Neurother; 2020 Nov; 20(11):1085-1098. PubMed ID: 33031714
[TBL] [Abstract][Full Text] [Related]
11. Number needed to treat and associated cost analysis of cenobamate versus third-generation anti-seizure medications for the treatment of focal-onset seizures in patients with drug-resistant epilepsy in Spain.
Villanueva V; Serratosa JM; Toledo M; Ángel Calleja M; Navarro A; Sabaniego J; Pérez-Domper P; Álvarez-Barón E; Subías S; Gil A
Epilepsy Behav; 2023 Feb; 139():109054. PubMed ID: 36603345
[TBL] [Abstract][Full Text] [Related]
12. Dose Adjustment of Concomitant Antiseizure Medications During Cenobamate Treatment: Expert Opinion Consensus Recommendations.
Smith MC; Klein P; Krauss GL; Rashid S; Seiden LG; Stern JM; Rosenfeld WE
Neurol Ther; 2022 Dec; 11(4):1705-1720. PubMed ID: 36057761
[TBL] [Abstract][Full Text] [Related]
13. Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA).
Falip M; López González FJ; Martín-Herranz I; Merino-Bohórquez V; Montoya J; Rey Gómez-Serranillos I; Rodriguez Uranga JJ; Ruiz E; Sancho-López A; Trillo Mata JL; Antoni Vallès J; Álvarez-Barón E; Sabaniego J; Subías-Labazuy S; Gil A
Epilepsy Behav; 2023 Aug; 145():109350. PubMed ID: 37480633
[TBL] [Abstract][Full Text] [Related]
14. Spanish consensus on the management of concomitant antiseizure medications when using cenobamate in adults with drug-resistant focal seizures.
Carreño M; Gil-Nagel A; Serratosa JM; Toledo M; Rodriguez-Uranga JJ; Villanueva V
Epilepsia Open; 2024 Jun; 9(3):1051-1058. PubMed ID: 38573131
[TBL] [Abstract][Full Text] [Related]
15. Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures.
Chung SS; French JA; Kowalski J; Krauss GL; Lee SK; Maciejowski M; Rosenfeld WE; Sperling MR; Mizne S; Kamin M
Neurology; 2020 Jun; 94(22):e2311-e2322. PubMed ID: 32409485
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open-label study.
Sperling MR; Abou-Khalil B; Aboumatar S; Bhatia P; Biton V; Klein P; Krauss GL; Vossler DG; Wechsler R; Ferrari L; Grall M; Rosenfeld WE
Epilepsia; 2021 Dec; 62(12):3005-3015. PubMed ID: 34633084
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of adjunctive cenobamate: Post-hoc analysis of study C017 in patients grouped by mechanism of action of concomitant antiseizure medications.
Brandt C; Sánchez-Álvarez JC; Steinhoff BJ; Milanov I; Serratosa JM
Seizure; 2022 Mar; 96():86-93. PubMed ID: 35168142
[TBL] [Abstract][Full Text] [Related]
18. Adjunctive use of cenobamate for pediatric refractory focal-onset epilepsy: A single-center retrospective study.
Varughese RT; Shah YD; Karkare S; Kothare SV
Epilepsy Behav; 2022 May; 130():108679. PubMed ID: 35381496
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of cenobamate for uncontrolled focal seizures in patients with previous epilepsy-related surgery: Post hoc analysis of a phase 3, multicenter, open-label study.
Abou-Khalil B; Aboumatar S; Klein P; Krauss GL; Sperling MR; Rosenfeld WE
Epilepsy Res; 2022 Aug; 184():106952. PubMed ID: 35671632
[TBL] [Abstract][Full Text] [Related]
20. Cenobamate treatment of focal-onset seizures: Quality of life and outcome during up to eight years of treatment.
Elizebath R; Zhang E; Coe P; Gutierrez EG; Yang J; Krauss GL
Epilepsy Behav; 2021 Mar; 116():107796. PubMed ID: 33567400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
